Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intestinal Microbiota Transplantation + Sintilimab + CAPOX + Radiotherapy in LARC
NCT07738042Phase 2Not yet recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of biologically active human fecal material in rectal cancer, sponsored by Tianjin Medical University Cancer Institute and Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
biologically active human fecal material
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07738042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07738042.